Revenue: The sum of all revenue fields included for a company's operating activities.
Ascendis Pharma A/S (ASND) had Revenue of $393.50M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$393.50M |
$-409.12M |
|
$47.89M |
|
$345.60M |
|
$695.15M |
|
$-301.65M |
|
$-102.23M |
|
$-403.88M |
|
$-403.88M |
|
$-409.12M |
|
$-409.12M |
|
$-409.12M |
|
$-409.12M |
|
$-301.65M |
|
$-282.48M |
|
57.89M |
|
57.89M |
|
$-7.07 |
|
$-7.07 |
|
| Balance Sheet Financials | |
$1.15B |
|
$106.82M |
|
$128.37M |
|
$1.28B |
|
$982.40M |
|
$395.05M |
|
$408.32M |
|
$1.39B |
|
$-114.38M |
|
$-118.74M |
|
$-114.38M |
|
60.69M |
|
| Cash Flow Statement Financials | |
$-331.34M |
|
$7.44M |
|
$480.38M |
|
$424.36M |
|
$605.48M |
|
$181.12M |
|
$103.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
1.41 |
|
-8.10 |
|
87.83% |
|
-76.66% |
|
-76.66% |
|
-71.79% |
|
-102.64% |
|
-103.97% |
|
$-331.85M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
0.15 |
|
2.05 |
|
178.10 |
|
357.68% |
|
344.55% |
|
-32.05% |
|
-145.77% |
|
$-1.88 |
|
$-5.73 |
|
$-5.72 |
|